Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Product Launch

6th Mar 2006 07:00

International Medical Devices PLC06 March 2006 . International Medical Devices gears up for NHS debut International Medical Devices (IMD or "the Company") is delighted to announcethat initial production runs of its ClipOnTM "safe" needle device have begun fordelivery into the NHS and also South Africa. Production is taking place at the Eastland Medical Systems plant in Portland,Australia, following IMD's acquisition of the patents over a range of safedevices from Eastland Technology Australia (ETA). The NHS Purchasing and Supply Agency currently buys 136 million needles peryear, of which 50 per cent are 21 gauge needles. The total UK market isestimated at approximately 200 million per year. IMD will initially target this21 gauge market, i.e. 70 million needles. IMD, with its associate company EMS,also intends to address the growing need for safe needles in sub-Saharan Africawhere HIV is causing such devastation. To this end it is working with the NelsonMandela Foundation. The World Health Organisation estimates that at least fiveper cent of HIV has been contracted through the use of unsterile needles. IMD'ssafe needles can be used once only and once retracted are fully secure. Trials begin in five NHS Trust hospitals of IMD's ClipOnTM safe needle devicelater this month and the needle buyer for the NHS Purchasing and Supply Agency(PASA) has agreed to support the fast-track launch of the Company's productsinto the Service for launch in April. The Company's assessment of the UK, European, South African and Australianmarkets indicates initial potential demand for the ClipOnTM safe retractableneedle is in the order of 300 million units annually. Volumes in excess of 100million units are anticipated to substantially reduce production costs and openup further markets. Last month IMD reported that it has enjoyed an outstanding six months followingthe acquisition of the medical distributor Meddis Ltd in September 2005, withMeddis sales for last November up by 29 per cent over the same month in 2004 andJanuary sales up 46 per cent on 2005. Chris Thomas, Chief Executive of IMD said: "We are now entering a period ofgreat activity and growth exactly in line with our stated strategy. We believewe can make a very real and valuable contribution to the safety of healthcarestaff in the NHS with the introduction of our cost effective, safe needles. Theoverall savings to the Service by eliminating days lost through needlestickinjuries - up to 100,000 each year - should be in the region of £10 millionannually". ABOUT IMD International Medical Devices plc was admitted to the AIM in November 2004 withthe purpose of acquiring companies or businesses operating in the health andmedical devices sector which have the prospect of delivering high return andsignificant capital growth. On July 18, 2005 an Extraordinary General Meeting approved a placing whichraised £750,000 before expenses. The meeting also approved the acquisition ofthe technology patents and distribution rights of ETA and EMS respectively. ETAand EMS are established Australian companies with manufacturing and distributionrights and technology rights primarily in the Southern hemisphere but also inNorth America, the UK and most of Europe. Contact: Alan Frame, Westport Communications Ltd 020 405 7777 07850 944187 Chris Thomas, International Medical Devices plc 020 7659 5216 07812 145350 This information is provided by RNS The company news service from the London Stock Exchange

Related Shares:

Intelliam Ai
FTSE 100 Latest
Value10,419.59
Change-33.09